Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print July 6, 2004
Protein Science, DOI: 10.1110/ps.04797104
Copyright © 2004 The Protein Society
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Research Data
Right arrow All Versions of this Article:
ps.04797104v1
13/8/2252    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devany, M.
Right arrow Articles by Matsuo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devany, M.
Right arrow Articles by Matsuo, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PROTEIN STRUCTURE REPORT

Solution NMR structure of the C-terminal domain of the human protein DEK

Matthew Devany, N. Prasad Kotharu and Hiroshi Matsuo

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA

(RECEIVED April 7, 2004; FINAL REVISION May 3, 2004; ACCEPTED May 3, 2004)

The chromatin-associated protein DEK was first identified as a fusion protein in patients with a subtype of acute myelogenous leukemia. It has since become associated with diverse human ailments ranging from cancers to autoimmune diseases. Despite much research effort, the biochemical basis for these clinical connections has yet to be explained. We have identified a structural domain in the C-terminal region of DEK [DEK(309–375)]. DEK(309–375) implies clinical importance because it can reverse the characteristic abnormal DNA-mutagen sensitivity in fibroblasts from ataxia-telangiectasia (A-T) patients. We determined the solution structure of DEK(309–375) by nuclear magnetic resonance spectroscopy, and found it to be structurally homologous to the E2F/DP transcription factor family. On the basis of this homology, we tested whether DEK(309–375) could bind DNA and identified the DNA-interacting surface. DEK presents a hydrophobic surface on the side opposite the DNA-interacting surface. The structure of the C-terminal region of DEK provides insights into the protein function of DEK.

Keywords: NMR structure; oncogene product; ataxia-telangiectasia; acute myeloid leukemia; chromatin-associated protein; chromosomal translocation

Abbreviations: DEK(309–375), deletion of the N-terminal 308 amino acids of the human DEK protein • AML, acute myelogenous leukemia • A-T, ataxia telangiectasia • JRA, juvenile rheumatoid arthritis • HSQC, hetero-nuclear single quantum coherence • NOE, nuclear Overhauser effect • RMSD, root mean square deviation


Reprint requests to: Hiroshi Matsuo, Department of Biochemistry, Molecular Biology and Biophysics, 321 Church Street, S.E. Jackson Hall 6-155, University of Minnesota, Minneapolis, MN 55455, USA; e-mail: matsu029{at}umn.edu; fax: (612) 625-2163.

Supplemental material: see www.proteinscience.org

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.04797104.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
M. Devany, F. Kappes, K.-M. Chen, D. M. Markovitz, and H. Matsuo
Solution NMR structure of the N-terminal domain of the human DEK protein
Protein Sci., February 1, 2008; 17(2): 205 - 215.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by The Protein Society.